Migraines In Women: How Hormones Influence Neurological Health
For those who have not experienced a migraine, perhaps it would seem just another headache. But for someone like me who has suffered through migraines that will last over a week even with medication, I can definitely tell you that it's much more. The ache is not confined to the head; it's the whole experience. Nausea, sensitivity to light, and throbs so bad it makes simple tasks unbearable. It also comes with an emotional burden—the loneliness and frustration are pretty unbearable. Through the years, realizing how hormones are also implicated in triggering and exacerbating my migraines has helped change the game in my dealing with these episodes.
Hormonal migraines are caused by fluctuations in estrogen and progesterone, the two main female hormones. These hormones are essential for the reproductive system, regulating menstrual cycles and pregnancy. They also have an effect on brain chemicals, such as serotonin and dopamine, which affect mood and pain perception. When hormone levels fluctuate, such as during menstruation, pregnancy, or menopause, they can destabilize the pathways in the brain, causing migraines.
According to Dr. Shivananda Pai, Consultant Neurology, migraines are more than a neurological disorder. "Migraines represent a complex interplay of genetic, environmental, and hormonal factors. In women, hormonal fluctuations are a critical trigger that amplifies sensitivity to pain," he explains. Hormonal headaches are particularly challenging because they are influenced by multiple life stages, from puberty to post-menopause. Common causes include:
Estrogen, often called the "hormone of femininity", does more than regulate reproductive functions. It is a powerful influencer of brain health. Estrogen modulates the activity of neurotransmitters like serotonin, which regulates mood and pain perception, and dopamine, associated with reward and pleasure.
During stages of hormonal stability, like in pregnancy's latter months, women may have fewer migraines because of the steady elevation of estrogen. However, a sudden downfall in estrogen destabilizes these chemicals in the brain, sending a heightened sensitivity for migraine triggers.
The most common form of hormonal migraines is menstrual migraines, which occur in response to the steep decline in estrogen levels just before menstruation. These are typically more intense and less responsive to standard treatment. The timing of these migraines provides clear evidence of the role hormones play in neurological health.
Pregnancy is a rollercoaster of hormones. Although many women experience relief from migraines as a result of the constantly elevated levels of estrogen, some women, particularly in the first trimester, worsen. This individual variability is a characteristic of hormonal migraine triggers.
Hormonal treatments, such as oral contraceptives and HRT, have had mixed reviews regarding their use in managing migraine. Some women fare better with the stabilization the treatment provides, whereas others suffer worsening symptoms. This will depend on the nature and dose of the hormones used.
For most women, menopause brings relief from their migraines. The decline in frequency and severity often accompanies stability in hormone levels. Even so, the susceptibility remains with some towards other forms of triggers including stress and sleep deprivation, not to forget diet-related factors and continues the saga of migraines well after the menopausal stages.
The relationship of hormones to neurological health goes beyond migraines. Hormonal changes have profound effects on a woman's brain in general.
Mood Disorders: Estrogen helps stabilize mood by regulating serotonin. Its decline at menopause increases the risk of mood swings and depression.
Neurodegenerative Diseases: Estrogen is neuroprotective, stimulating the growth and repair of brain cells. Its absence in post-menopausal women has been associated with an increased risk of Alzheimer's disease and cognitive decline.
Multiple Sclerosis (MS): Hormonal cycles may affect the course of MS, a disease that occurs more frequently in women than in men. Estrogen's anti-inflammatory effects provide transient protection during pregnancy, reducing relapse rates in women with MS.
"The intricate interplay between hormones and neurological health underscores the need for gender-specific treatment approaches," says Dr. Pai.
While hormonal changes are inevitable, several strategies can help manage migraines effectively:
Understanding your menstrual cycle can help identify patterns and predict when migraines might occur. This knowledge allows for preventive measures, such as scheduling medications or adjusting lifestyle habits.
Working with a neurologist or gynecologist can help develop a personalized treatment plan. Options might include hormonal therapies, triptans, or preventive medications tailored to your specific needs.
A well-balanced diet, regular exercise, and stress management are all integral parts of managing migraines. For instance, magnesium-rich foods and hydration can help reduce the frequency and severity of attacks.
For people with severe or frequent migraines, preventive medications, such as beta-blockers or CGRP inhibitors, may be prescribed. These medications stabilize brain activity and therefore reduce the chances of migraine during hormonal fluctuations.
Techniques like yoga, meditation, and biofeedback can enhance wellness and reduce the debilitating effects of stress-one of the most common migraine triggers.
Research that was once in its embryonic stage continues to shed more light on the role of hormones in migraines and other neurological conditions. Further breakthroughs in genetic testing might enable doctors to predict, at least in a way, how an individual would react to hormonal therapies. The importance of gender-specific approaches is gradually being realized, which involves differentiating between the plight of women with migraines from others.
As Dr. Pai puts it, "Empowering women with knowledge about the hormonal underpinnings of migraines can lead to better, more personalized care. With the right strategies, migraines can be effectively managed, allowing women to lead fuller, healthier lives.
Migraines are not headaches; they are a complex neurological condition that deeply impacts the lives of millions of women. Understanding the role of hormones in triggering and exacerbating migraines is a vital step toward better management and relief.
Awareness, proactive care, and advances in medical research can help women regain their lives from the grip of hormonal migraines. Whether tracking cycles, adopting healthier habits, or seeking tailored medical care, every step taken toward understanding and managing migraines is a step toward empowerment.
Dr Shivananda Pai is a Consultant Neurology at KMC Hospital Dr B R Ambedkar Circle in Mangalore, India.
Brandes JL. The Influence of Estrogen on Migraine: A Systematic Review. JAMA. 2006;295(15):1824–1830. doi:10.1001/jama.295.15.1824
Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012 Apr;13(3):177-89. doi: 10.1007/s10194-012-0424-y. Epub 2012 Feb 26. PMID: 22367631; PMCID: PMC3311830.
Credit: AI
Doctors have reached a major milestone in minimally invasive lung care. They have removed a suspected endobronchial carcinoid tumor from a patient's airway without needing to perform open chest surgery. The procedure combined four advanced bronchoscopic techniques to successfully remove the tumour while saving the patient’s lung tissue.
A 40 year old male patient from Gurugram came in with breathlessness. Additional examinations revealed partially obstructing the airway and interfering with the patient’s normal breathing. Because of where the tumour was and what it looked like, doctors decided to do the advanced bronchoscopic procedure rather than a more invasive surgery.
Also read: Is It Just A Persistent Cough Or Is Your Body Telling You Something Else?
Endobronchial carcinoid tumours are slow growing but highly vascular and can bleed profusely when excised. Precise instrumentation, careful planning and efficient control of bleeding are required to treat them within the narrow air passage. To overcome these challenges the team employed a multimodality approach that included flexible fibreoptic bronchoscopy to access and visualise the tumour, electrocautery to cut and debulk the growth, Argon Plasma Coagulation (APC) to seal blood vessels and control bleeding and cryotherapy to freeze and extract tumour tissue and treat the residual base.
The combined approach allowed the team to completely remove the tumour and restore airway patency with no need for an external incision. The patient [recovered well and was discharged within X days/is recovering well], while the excised tissue has been sent for histopathological examination to confirm the diagnosis.
Endobronchial tumours such as carcinoids can bleed heavily, so every step has to be planned in advance. By combining electrocautery, argon plasma coagulation and cryotherapy through a flexible bronchoscope, we were able to remove the tumour completely while keeping bleeding under control. For carefully selected patients, this approach can avoid open surgery and the loss of healthy lung tissue.
Traditionally, some endobronchial tumours have required surgical removal of the affected portion of the lung. Advances in interventional pulmonology are expanding treatment possibilities, allowing appropriately selected patients to undergo tumour removal through the natural airway. This approach can help avoid external incisions as well as reduce post procedure pain, shorten hospital stays and support faster recovery.
This achievement shows just how important advanced therapeutic bronchoscopy has become for treating complex airway conditions.
Credit: AI
Lung cancer is usually linked to smoking yet there is more to the tale behind who gets the disease in India. More men suffer from lung cancer than women. This does not happen by coincidence because of the differences in the number of smokers.
According to the Global Cancer Observatory (GLOBOCAN 2022), lung cancer is one of the most common cancers among Indian males. There is a substantial difference in the prevalence rate of cancer between men and women, and the former group bears a higher burden of the disease. One needs to go deeper into the problem to find an explanation.
Tobacco consumption is one of the most important factors influencing the likelihood of suffering from cancer. Traditionally, smoking was a practice more common among men in India. According to the results of the Global Adult Tobacco Survey (GATS-2, 2016-17), about 24 per cent of Indian men had ever consumed tobacco, compared to just 14 per cent of women.
Cigarette smoke and bidis contain harmful chemicals that cause gradual damage to the tissues lining the airways. Such repeated exposure makes changes in genes more probable, which ultimately results in the occurrence of cancer. Moreover, the risk becomes higher depending on the length and severity of smoking.
Gender differences in the workforce in India may contribute to additional exposure to cancer-causing substances as well. Male employees in such occupations as construction, mining, manufacturing, transportation and some industries may be exposed to asbestos, silica dust, diesel engine exhausts and other hazardous agents. As a result, they become at greater risk of developing lung cancer due to long-term exposure.
Air pollution may contribute to an increase in the risk of lung cancer as well. Inhalation of fine particulates, especially PM2.5, is able to penetrate deeply into the lungs and cause cancer. According to IARC, outdoor air pollution and particulate matter are carcinogenic to humans.
Nevertheless, women may suffer from environmental risk factors too. Inhalation of smoke caused by solid fuel combustion in kitchens with poor ventilation and passive exposure to cigarette smoke pose additional risks for female patients.
Also read: Lung Cancer Survival Improves By 71% In US: But 1 In 5 Patients Still Gets No Treatment
One common myth is that lung cancer only affects smokers. Some women develop lung cancer without any history of smoking. Some lung cancers, especially some kinds of adenocarcinomas, occur in people with no past of smoking. These cancers could have unique features and genetic mutations that could assist in identifying targeted therapy for this condition.
This is why an individual assessment of each case of lung cancer is necessary rather than jumping to conclusions about what caused the cancer based on whether one smokes or not.
While men might disregard cough, shortness of breath, or chest pains as being results of smoking, pollution, or age, women might struggle with the same problem due to the fact that they do not smoke.
A persistent cough for weeks, bloody sputum, unintentional weight loss, constant chest pain, or an increasing level of breathlessness is never to be dismissed. Symptoms like these do not always mean cancer, yet they need a proper medical evaluation.
Gender differences in the incidence of lung cancer depend on behavioral, environmental, occupational, and biological factors. It is essential to stop smoking, create safe workplaces, reduce pollution of the air, and have an early diagnosis for both men and women.
Lung cancer cannot be viewed as a man's disease or the outcome of smoking. The chances might differ, but it needs to be universally recognized and treated.
Credit: iStock
Even if diabetes is kept under control kidney function can still get worse over time. Good control of blood sugar cuts the risk of kidney disease a lot but it does not remove the risk entirely.
The risk depends on things, such as how long one has had diabetes years of poor blood sugar control, high blood pressure being overweight genes and heart disease. Sometimes kidney damage that started when blood sugar was high before can keep showing up after blood sugar improves later.
One key point is that HbA1c by itself does not show kidney health. A person may have a HbA1c of 6.5 percent yet still have early kidney damage with no signs. That is why regular kidney screening is vital.
I recommend two tests for every person with diabetes: urine albumin-to-creatinine ratio, called UACR and estimated glomerular filtration rate, called eGFR. These tests reveal kidney damage early before any symptoms. People with type 2 diabetes should have these tests at once a year.
In addition to blood sugar control keeping blood pressure low staying at a healthy weight exercising often avoiding needless painkillers and quitting smoking are key ways to protect kidneys. New medicines, SGLT2 inhibitors and for some people, finerenone have shown strong kidney protection
Controlling blood sugar matters. Protecting kidneys needs more than just diabetes control. Regular screening and early treatment can greatly lower the chance of kidney disease and the need, for dialysis.
By Dr. Ronak Bhalodia, Dr NB Nephrology, MD Medicine, Sterling Hospital, Rajkot
© $2026 Times Horizon Private Limited